Prevalence Of Oral Mucosal Alterations In Diabetes Mellitus Type2
1 other identifier
observational
500
1 country
1
Brief Summary
There are severe deficiency of database concerning the oral health status in Egyptian patients with Diabetes type 2. Our aim in the present study is to study the prevalence of oral mucosal alterations in type 2 DM patients and the effect of hyperglycemia on these alterations in controlled and uncontrolled patients to increase their awareness and minimize all the possible risk factors,to achieve a proper management for all oral problems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2018
CompletedFirst Posted
Study publicly available on registry
September 14, 2018
CompletedStudy Start
First participant enrolled
December 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2019
CompletedJanuary 28, 2020
January 1, 2020
7 months
September 12, 2018
January 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oral mucosal alterations
Clinical examination according to WHO guidelines by Dichotomous outcome (Yes/No).
10 min
Secondary Outcomes (2)
Periodontal condition
10 min
Salivary glands function
10 min
Study Arms (2)
controlled diabetic patients
uncontrolled diabetic patients
Eligibility Criteria
A convenience sample of adult patients diagnosed with diabetes type 2 attending at the Endocrine clinic at El Kasr Al-Ainy Cairo University Hospital will be enrolled in the study in a consecutive order.
You may qualify if:
- Adult patients
- Patients \>25years old
- Patients diagnosed with diabetes type 2.
- Egyptian patients.
You may not qualify if:
- females diagnosed with gestational diabetes.
- Patients not physically able to participate in survey or clinical oral examination.
- Patients with other systemic diseases which may cause oral manifestation as liver disorders.
- Patients under immunosuppressive drugs.
- Patients under corticosteriods.
- Patients with organ transplantation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alaa Mahmoud abd El kaderlead
- Cairo Universitycollaborator
Study Sites (1)
Alaa Mahmoud Abd El Kader
Cairo, 2020, Egypt
Related Publications (2)
Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital universiti sains malaysia. Malays J Med Sci. 2013 Jul;20(4):39-46.
PMID: 24043995RESULTBastos AS, Leite AR, Spin-Neto R, Nassar PO, Massucato EM, Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract. 2011 Apr;92(1):100-5. doi: 10.1016/j.diabres.2011.01.011. Epub 2011 Mar 3.
PMID: 21300417RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mariam fakhr
the Endocrine units at the Kasr Al-Ainy Cairo university hospital.
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principle investigator, internal resident at oral medicine department
Study Record Dates
First Submitted
September 12, 2018
First Posted
September 14, 2018
Study Start
December 25, 2018
Primary Completion
July 30, 2019
Study Completion
August 20, 2019
Last Updated
January 28, 2020
Record last verified: 2020-01